In a scorching review, the FDA makes it fairly clear that Melblez will not be approved until Delcath conducts a new clinical trial.
http://www.thestreet.com/story/11909450/1/fda-tells-delcath-no-approval-without-new-clinical-trial.html?cm_ven=RSSFeed&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+tsc%2Ffeeds%2Frss%2Flatest-stories+%28TheStreet.com+Latest+Headlines%29
http://www.thestreet.com/story/11909450/1/fda-tells-delcath-no-approval-without-new-clinical-trial.html?cm_ven=RSSFeed&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+tsc%2Ffeeds%2Frss%2Flatest-stories+%28TheStreet.com+Latest+Headlines%29
No comments:
Post a Comment